Mechanistically, hepatocyte IRF6 bound directly to the promoter of the PPARγ gene and subsequently stopped transcription of PPARγ and its target genes (regulating adipogenesis and fatty acid uptake), resulting in amelioration of NAFLD progression [59]. The gene discussed is IRF6; the disease is metabolic dysfunction-associated steatotic liver disease.